200 likes | 335 Views
Support to WHO ACTs Project. Guilin Pharmaceutical Co,.Ltd. 22 Mar 2006. 1. Advantage on ACTs resource. 1.1 Guilin Pharma has established its own Artesunate industrial chain. Artesunate Industrial Chain. Extraction. ARTESUNATE. Seeds selection. Cultivation. Amodiaquine.
E N D
Support to WHO ACTs Project Guilin Pharmaceutical Co,.Ltd. 22 Mar 2006
1. Advantage on ACTs resource 1.1 Guilin Pharma has established its own Artesunate industrial chain
Artesunate Industrial Chain Extraction ARTESUNATE Seeds selection Cultivation Amodiaquine Amodiaquine Tablets ARSUAMOON (AS+AQ) ARTESUNATE Tablets ARTESUNATE for Injection
ARSUAMOON (AS+AQ) production line
1.2 In Feb of 2006, Guilin Pharma built up the large-scale plantation base in Guangxi, Hunan and Sichuan province of China, which covers an area of 70 million ~ 75 million M2.
1.3 Production capacity Million
2 Established Quality Assurance System 2.1The products are manufactured and conform to WHO GMP requirement
2.2 The products specifications conform to the WHO required standards IP USP BP
2.3 ARTESUNATE Tablets has been listed in WHO pre-qualification Programme
3. To reduce cost to make ACTs affordable Improve the manufactory capacity to supply ACTs, to make every effort to reduce the cost a. Manufactory Cost b. Management Cost To supply ACTs at reasonable price
4. Guilin Pharma ACTs 4.1 ARSUAMOON Artesunate Tablets + Amodiaquine Hydrochloride Tablets
4.2 ARTECOSPE Artesunate Tablets + Sulfadoxine/Pyrimethamine Tablets
5. Research & Development on New Antimalarial 5.1 Antimalarial for infant and children 5.2 Artesunate fixed-dosage 5.3 Artesunate for Injection (new and more convenient use)
Thank you! Welcome to Guilin